OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ethnic-specific meta-analyses of association between the OPRM1 A118G polymorphism and alcohol dependence among Asians and Caucasians
Dingyan Chen, Li Liu, Yang Xiao, et al.
Drug and Alcohol Dependence (2011) Vol. 123, Iss. 1-3, pp. 1-6
Closed Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts
Tae‐Hwi Schwantes‐An, Juan Zhang, Li‐Shiun Chen, et al.
Behavior Genetics (2015) Vol. 46, Iss. 2, pp. 151-169
Open Access | Times Cited: 114

The etiologic, theory-based, ontogenetic hierarchical framework of alcohol use disorder: A translational systematic review of reviews.
Cassandra L. Boness, Ashley L. Watts, Kimberly N. Moeller, et al.
Psychological Bulletin (2021) Vol. 147, Iss. 10, pp. 1075-1123
Open Access | Times Cited: 57

Pharmacogenetics of OPRM1
Richard C. Crist, Wade H. Berrettini
Pharmacology Biochemistry and Behavior (2013) Vol. 123, pp. 25-33
Open Access | Times Cited: 99

Meta-analysis of six genes (BDNF, DRD1, DRD3, DRD4, GRIN2B and MAOA) involved in neuroplasticity and the risk for alcohol dependence
Diego A. Forero, Sandra López‐León, Hyoung Doo Shin, et al.
Drug and Alcohol Dependence (2015) Vol. 149, pp. 259-263
Closed Access | Times Cited: 48

Alcoholism and liver disease in Mexico: Genetic and environmental factors
Sonia Román, Eloy Alfonso Zepeda-Carrillo, Laura E. Moreno-Luna, et al.
World Journal of Gastroenterology (2013) Vol. 19, Iss. 44, pp. 7972-7972
Open Access | Times Cited: 48

The distribution of new HIV infections by mode of exposure in Morocco
Ghina R. Mumtaz, Silva P. Kouyoumjian, Nahla Hilmi, et al.
Sexually Transmitted Infections (2013) Vol. 89, Iss. Suppl 3, pp. iii49-iii56
Open Access | Times Cited: 47

Alcohol consumption and incidence of type 2 diabetes. Results from the CoLaus study
Pedro Marques‐Vidal, Péter Vollenweider, Gérard Waeber
Nutrition Metabolism and Cardiovascular Diseases (2014) Vol. 25, Iss. 1, pp. 75-84
Closed Access | Times Cited: 39

Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential
Michael Soyka
Expert Opinion on Pharmacotherapy (2016) Vol. 17, Iss. 4, pp. 619-626
Closed Access | Times Cited: 36

µ-Opioid Receptor Gene (OPRM1) Polymorphism A118G: Lack of Association in Finnish Populations with Alcohol Dependence or Alcohol Consumption
Noora Rouvinen-Lagerström, Jari Lahti, Hannu Alho, et al.
Alcohol and Alcoholism (2013) Vol. 48, Iss. 5, pp. 519-525
Open Access | Times Cited: 30

Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity
Anita Cservenka, Megan M. Yardley, Lara A. Ray
American Journal on Addictions (2016) Vol. 26, Iss. 5, pp. 516-525
Open Access | Times Cited: 26

Alteraciones neurobiológicas en el alcoholismo: revisión
Amaia M. Erdozain, Luís F. Callado
Adicciones (2014) Vol. 26, Iss. 4, pp. 360-360
Open Access | Times Cited: 25

The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption
Matthew E. Sloan, Timothy Klepp, Joshua L. Gowin, et al.
Neuropsychopharmacology (2018) Vol. 43, Iss. 7, pp. 1530-1538
Open Access | Times Cited: 25

Pharmacotherapies and Personalized Medicine for Alcohol Use Disorder: A Review
Falk W. Lohoff
Pharmacogenomics (2020) Vol. 21, Iss. 15, pp. 1117-1138
Open Access | Times Cited: 23

The genetics of alcohol dependence: Advancing towards systems-based approaches
Rohan H. C. Palmer, John E. McGeary, Sarah Francazio, et al.
Drug and Alcohol Dependence (2012) Vol. 125, Iss. 3, pp. 179-191
Open Access | Times Cited: 26

Influence of theOPRM1A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone
Elaine Setiawan, Robert O. Pihl, Chawki Benkelfat, et al.
Pharmacogenomics (2012) Vol. 13, Iss. 10, pp. 1161-1172
Closed Access | Times Cited: 20

Smoking behaviour in pregnancy and its impact on smoking cessation at various intervals during follow‐up over 21 years: a prospective cohort study
Divya Rattan, Abdullah Al Mamun, Jake M. Najman, et al.
BJOG An International Journal of Obstetrics & Gynaecology (2012) Vol. 120, Iss. 3, pp. 288-296
Closed Access | Times Cited: 19

Association between Opioid Receptor mu 1 (OPRM1) Gene Polymorphisms and Tobacco and Alcohol Consumption in a Spanish Population
Francesc Francès, Olga Portolés, Ana Castelló Ponce, et al.
Biomolecules and Biomedicine (2015) Vol. 15, Iss. 2, pp. 31-36
Open Access | Times Cited: 17

Alcohol Consumption in HealthyOPRM1G Allele Carriers and Its Association with Impulsive Behavior
Philippe Pfeifer, Murat Sariyar, Thomas Eggermann, et al.
Alcohol and Alcoholism (2015) Vol. 50, Iss. 4, pp. 379-384
Open Access | Times Cited: 16

Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype
Hisham Ziauddeen, Liam J. Nestor, Naresh Subramaniam, et al.
Neuropsychopharmacology (2016) Vol. 41, Iss. 11, pp. 2647-2657
Open Access | Times Cited: 16

Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial
Lara A. Ray, ReJoyce Green, Daniel Roche, et al.
Alcoholism Clinical and Experimental Research (2017) Vol. 42, Iss. 3, pp. 613-623
Open Access | Times Cited: 16

A cis‐eQTL in OPRM1 is Associated with Subjective Response to Alcohol and Alcohol Use
Jacqueline M. Otto, Ian R. Gizer, Joseph D. Deak, et al.
Alcoholism Clinical and Experimental Research (2017) Vol. 41, Iss. 5, pp. 929-938
Open Access | Times Cited: 15

Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of OPRM1 A/G Polymorphism on Its Effectiveness
Audrey Verholleman, Caroline Victorri‐Vigneau, Edouard‐Jules Laforgue, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 3002-3002
Open Access | Times Cited: 14

Page 1 - Next Page

Scroll to top